MedTrace Logo

A First Time in Human Study in Healthy Volunteers and Patients

NCT03010787 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2017-01-05

No results posted yet for this study

Summary

A multi-part study to investigate the safety, tolerability and local and systemic pharmacokinetics of V565

Conditions

Interventions

DRUG

V565

single ascending dose of V565

DRUG

V565

Multiple dose

DRUG

Placebo

Single and multiple dose

DRUG

V565

Open-label single dose

DRUG

V565

Open-label single ascending dose

Sponsors & Collaborators

  • VHsquared Ltd.

    lead INDUSTRY

Principal Investigators

  • Suhail Nurbhai, MBChB · VHsquared Ltd.

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010787 on ClinicalTrials.gov